AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39

Authors: CLELAND JL
Citation: Jl. Cleland, SOLVENT EVAPORATION PROCESSES FOR THE PRODUCTION OF CONTROLLED-RELEASE BIODEGRADABLE MICROSPHERE FORMULATIONS FOR THERAPEUTICS AND VACCINES, Biotechnology progress, 14(1), 1998, pp. 102-107

Authors: HERBERT P MURPHY K JOHNSON O DONG N JAWOROWICZ W TRACY MA CLELAND JL PUTNEY SD
Citation: P. Herbert et al., A LARGE-SCALE PROCESS TO PRODUCE MICROENCAPSULATED PROTEINS, Pharmaceutical research, 15(2), 1998, pp. 357-361

Authors: CLELAND JL
Citation: Jl. Cleland, AN EDITORS FAREWELL, The Journal of the American Animal Hospital Association, 34(5), 1998, pp. 361-361

Authors: KENDRICK BS CARPENTER JF CLELAND JL RANDOLPH TW
Citation: Bs. Kendrick et al., A TRANSIENT EXPANSION OF THE NATIVE-STATE PRECEDES AGGREGATION OF RECOMBINANT HUMAN INTERFERON-GAMMA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(24), 1998, pp. 14142-14146

Authors: KENDRICK BS CLELAND JL LAM X NGUYEN T RANDOLPH TW MANNING MC CARPENTER JF
Citation: Bs. Kendrick et al., AGGREGATION OF RECOMBINANT HUMAN INTERFERON-GAMMA - KINETICS AND STRUCTURAL TRANSITIONS, Journal of pharmaceutical sciences, 87(9), 1998, pp. 1069-1076

Authors: JOHNSON OL JAWOROWICZ W CLELAND JL BAILEY L CHARNIS M DUENAS E WU CC SHEPARD D MAGIL S LAST T JONES AJS PUTNEY SD
Citation: Ol. Johnson et al., THE STABILIZATION AND ENCAPSULATION OF HUMAN GROWTH-HORMONE INTO BIODEGRADABLE MICROSPHERES, Pharmaceutical research, 14(6), 1997, pp. 730-735

Authors: CLELAND JL MAC A BOYD B YANG J DUENAS ET YEUNG D BROOKS D HSU C CHU H MUKKU V JONES AJS
Citation: Jl. Cleland et al., THE STABILITY OF RECOMBINANT HUMAN GROWTH-HORMONE IN POLY(LACTIC-CO-GLYCOLIC ACID) (PLGA) MICROSPHERES, Pharmaceutical research, 14(4), 1997, pp. 420-425

Authors: CLELAND JL JOHNSON OL PUTNEY S JONES AJS
Citation: Jl. Cleland et al., RECOMBINANT HUMAN GROWTH-HORMONE POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERE FORMULATION DEVELOPMENT, Advanced drug delivery reviews, 28(1), 1997, pp. 71-84

Authors: HANES J CLELAND JL LANGER R
Citation: J. Hanes et al., NEW ADVANCES IN MICROSPHERE-BASED SINGLE-DOSE VACCINES, Advanced drug delivery reviews, 28(1), 1997, pp. 97-119

Authors: OKUMU FW CLELAND JL BORCHARDT RT
Citation: Fw. Okumu et al., THE EFFECT OF SIZE, CHARGE AND CYCLIZATION OF MODEL PEPTIDES ON THEIRIN-VITRO RELEASE FROM DL-PLGA MICROSPHERES, Journal of controlled release, 49(2-3), 1997, pp. 133-140

Authors: CLELAND JL DUENAS E DAUGHERTY A MARIAN M YANG J WILSON M CELNIKER AC SHAHZAMANI A QUARMBY V CHU H MUKKU V MAC A ROUSSAKIS M GILLETTE N BOYD B YEUNG D BROOKS D MAA YF HSU C JONES AJS
Citation: Jl. Cleland et al., RECOMBINANT HUMAN GROWTH-HORMONE POLY(LACTIC-CO-GLYCOLIC ACID) (PLGA)MICROSPHERES PROVIDE A LONG-LASTING EFFECT, Journal of controlled release, 49(2-3), 1997, pp. 193-205

Authors: CLELAND JL LIM A BARRON L DUENAS ET POWELL MF
Citation: Jl. Cleland et al., DEVELOPMENT OF A SINGLE-SHOT SUBUNIT VACCINE FOR HIV-1 .4. OPTIMIZINGMICROENCAPSULATION AND PULSATILE RELEASE OF MN RGP120 FROM BIODEGRADABLE MICROSPHERES, Journal of controlled release, 47(2), 1997, pp. 135-150

Authors: LEE HJ RILEY G JOHNSON O CLELAND JL KIM N CHARNIS M BAILEY L DUENAS E SHAHZAMANI A MARIAN M JONES AJS PUTNEY SD
Citation: Hj. Lee et al., IN-VIVO CHARACTERIZATION OF SUSTAINED-RELEASE FORMULATIONS OF HUMAN GROWTH-HORMONE, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1431-1439

Authors: YANG J CLELAND JL
Citation: J. Yang et Jl. Cleland, FACTORS AFFECTING THE IN-VITRO RELEASE OF RECOMBINANT HUMAN INTERFERON-GAMMA (RHIFN-GAMMA) FROM PLGA MICROSPHERES, Journal of pharmaceutical sciences, 86(8), 1997, pp. 908-914

Authors: LAM XM YANG JY CLELAND JL
Citation: Xm. Lam et al., ANTIOXIDANTS FOR PREVENTION OF METHIONINE OXIDATION IN RECOMBINANT MONOCLONAL-ANTIBODY HER2, Journal of pharmaceutical sciences, 86(11), 1997, pp. 1250-1255

Authors: BRAZIL BT CLELAND JL MCDOWELL RS SKELTON NJ PARIS K HOROWITZ PM
Citation: Bt. Brazil et al., MODEL PEPTIDE STUDIES DEMONSTRATE THAT AMPHIPATHIC SECONDARY STRUCTURES CAN BE RECOGNIZED BY THE CHAPERONIN GROEL (CPN60), The Journal of biological chemistry, 272(8), 1997, pp. 5105-5111

Authors: BAM NB CLELAND JL RANDOLPH TW
Citation: Nb. Bam et al., MOLTEN GLOBULE INTERMEDIATE OF RECOMBINANT HUMAN GROWTH-HORMONE - STABILIZATION WITH SURFACTANTS, Biotechnology progress, 12(6), 1996, pp. 801-809

Authors: JOHNSON OL CLELAND JL LEE HJ CHARNIS M DUENAS E JAWOROWICZ W SHEPARD D SHAHZAMANI A JONES AJS PUTNEY SD
Citation: Ol. Johnson et al., A MONTH-LONG EFFECT FROM A SINGLE INJECTION OF MICROENCAPSULATED HUMAN GROWTH-HORMONE, Nature medicine, 2(7), 1996, pp. 795-799

Authors: CLELAND JL JONES AJS
Citation: Jl. Cleland et Ajs. Jones, STABLE FORMULATIONS OF RECOMBINANT HUMAN GROWTH-HORMONE AND INTERFERON-GAMMA FOR MICROENCAPSULATION IN BIODEGRADABLE MICROSPHERES, Pharmaceutical research, 13(10), 1996, pp. 1464-1475

Authors: WEISSBURG RP BERMAN PW CLELAND JL EASTMAN D FARINA F FRIE S LIM A MORDENTI J NGUYEN TT PETERSON MR YIM K POWELL MF
Citation: Rp. Weissburg et al., CHARACTERIZATION OF THE MN GP120 HIV-1 VACCINE - ANTIGEN-BINDING TO ALUM (VOL 12, PG 1439, 1995), Pharmaceutical research, 13(1), 1996, pp. 183-183

Authors: CLELAND JL
Citation: Jl. Cleland, BABESIA IN RACING GREYHOUNDS, The Journal of the American Animal Hospital Association, 32(5), 1996, pp. 376-376

Authors: JONES AJS CLELAND JL
Citation: Ajs. Jones et Jl. Cleland, TECHNICAL AND REGULATORY HURDLES IN DELIVERY ASPECTS OF MACROMOLECULAR DRUGS, Journal of controlled release, 41(1-2), 1996, pp. 147-155

Authors: CLELAND JL BARRON L BERMAN PW DAUGHERTY A GREGORY T LIM A VENNARI J WRIN T POWELL MF
Citation: Jl. Cleland et al., DEVELOPMENT OF A SINGLE-SHOT SUBUNIT VACCINE FOR HIV-1 .2. DEFINING OPTIMAL AUTOBOOST CHARACTERISTICS TO MAXIMIZE THE HUMORAL IMMUNE-RESPONSE, Journal of pharmaceutical sciences, 85(12), 1996, pp. 1346-1349

Authors: CLELAND JL BARRON L DAUGHERTY A EASTMAN D KENSIL C LIM A WEISSBURG RP WRIN T VENNARI J POWELL MF
Citation: Jl. Cleland et al., DEVELOPMENT OF A SINGLE-SHOT SUBUNIT VACCINE FOR HIV-1 .3. EFFECT OF ADJUVANT AND IMMUNIZATION SCHEDULE ON THE DURATION OF THE HUMORAL IMMUNE-RESPONSE TO RECOMBINANT MN GP120, Journal of pharmaceutical sciences, 85(12), 1996, pp. 1350-1357

Authors: CLELAND JL KENSIL CR LIM A JACOBSEN NE BASA L SPELLMAN M WHEELER DA WU JY POWELL MF
Citation: Jl. Cleland et al., ISOMERIZATION AND FORMULATION STABILITY OF THE VACCINE ADJUVANT QS-21, Journal of pharmaceutical sciences, 85(1), 1996, pp. 22-28
Risultati: 1-25 | 26-39